Preventing Therapy Resistance in Esophageal Cancer Using Advanced Models and Molecular Signatures

Projektinformationen

PRESSURE

ID Finanzhilfevereinbarung: 101119464

DOI

10.3030/101119464

EK-Unterschriftsdatum 6 Juli 2023

Startdatum 1 Februar 2024

Enddatum 31 Januar 2028

Finanziert unter

Marie Skłodowska-Curie Actions (MSCA)

Gesamtkosten

Keine Daten

EU-Beitrag

€ 2 717 755,20

Koordiniert durch

STICHTING AMSTERDAM UMC
Netherlands

CORDIS bietet Links zu öffentlichen Ergebnissen und Veröffentlichungen von HORIZONT-Projekten.

Links zu Ergebnissen und Veröffentlichungen von RP7-Projekten sowie Links zu einigen Typen spezifischer Ergebnisse wie Datensätzen und Software werden dynamisch von OpenAIRE abgerufen.

Leistungen

Plan for the dissemination and exploitation of results, including communication activities (1)

Plan for the dissemination and exploitation of results, including communication activities, submitted at mid-term (M13) and an update towards the end of the project (M48)

Omics data interrogation

Omics data package queried & candidate signaling molecules are targeted

EAC models

EAC model panel curated, propagation standardized, and shared between consortium members and interested researchers

Patient outreach

Communication to patients and relatives via ECPC press releases, newsletter, website and social media

Test stromal profiles

Pre-established stromal profiles are tested in materials from PRESSURE biobanks

Define contributions of EMT and purported CSCs

Define contributions of EMT and purported CSC populations to therapy resistance

Establish IP Board

IP board is established, Oncode supervises IP management